TABLE 2

Prevalence of diabetes in relation to ISP levels and BMI

BMI (kg/m2)
All men
<2525–29.9≥30
n3,2972,3184356,050
Men with diabetes (n)11813073321
Fibrinogen Q1–3 vs. Q4 (% with diabetes)3.4 vs. 4.24.8 vs. 7.814.2 vs. 21.64.6 vs. 7.3
Haptoglobin Q1–3 vs. Q4 (% with diabetes)3.7 vs. 3.24.7 vs. 8.414.8 vs. 21.64.8 vs. 6.7
Ceruloplasmin Q1–3 vs. Q4 (% with diabetes)3.4 vs. 4.25.3 vs. 6.716.3 vs. 18.45.0 vs. 6.3
Orosomucoid Q1–3 vs. Q4 (% with diabetes)3.9 vs. 2.75.1 vs. 6.914.6 vs. 20.95.0 vs. 6.1
α1-Antitrypsin Q1–3 vs. Q4 (% with diabetes)3.4 vs. 3.95.4 vs. 6.215.9 vs. 19.25.1 vs. 5.8
No ISP in top Q (% with diabetes, n/n)3.3 (45/1,373)3.8 (35/930)13.9 (19/137)4.1 (99/2,440)
One ISP in top Q (% with diabetes, n/n)4.0 (33/816)6.3 (39/621)12.8 (15/117)5.6 (87/1,554)
Two ISPs in top Q (% with diabetes, n/n)3.3 (16/490)6.7 (23/341)20.8 (15/72)6.0 (54/903)
Three ISPs in top Q (% with diabetes, n/n)5.4 (16/299)6.9 (16/231)16.9 (10/59)7.1 (42/589)
Four or five ISPs in top Q (% with diabetes, n/n)2.5 (8/319)8.7 (17/195)28.0 (14/50)6.9 (39/564)
Zero to one ISP in top Q (% with diabetes)3.64.813.44.7
Two to five ISPs in top Q (% with diabetes)3.67.321.56.6
Adjusted OR for diabetes in men with two to five ISPs*1.09 (0.72–1.6)1.64 (1.13–2.4)1.74 (1.03–3.0)1.39 (1.09–1.77)
  • *

    * Adjusted for age, physical activity, smoking, and BMI (all men only). OR, odds ratio; Q, quartile.